Form 4: CFO Jack Anders Sells RVMD Stock for Tax Obligations
Insider Transaction Report
Revolution Medicines CFO Jack Anders sold 2,753 shares of common stock to cover tax withholding on RSU vesting, as per a pre-arranged 10b5-1 plan.
Summary
- Jack Anders, Chief Financial Officer of Revolution Medicines, Inc. (RVMD), reported a sale of 2,753 shares of common stock.
- The transaction occurred on March 17, 2026, at a price of $99.4804 per share.
- This sale was executed under a Rule 10b5-1 instruction letter adopted on May 31, 2023.
- The purpose of the sale was to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) after July 15, 2023.
- Following this transaction, Jack Anders beneficially owns 125,512 shares of common stock, which includes 56,600 RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine, administrative insider transaction for tax purposes, executed under a pre-arranged plan, and therefore carries a neutral sentiment regarding the company's operational or financial performance.
Positives
- The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating a structured approach to managing insider stock transactions and reducing concerns about opportunistic selling.
- The sale was specifically for tax withholding obligations related to RSU vesting, which implies the underlying RSUs vested, a positive event for the reporting person.
Industry Context
StockSavvy.ai notes that this Form 4 filing represents a routine, administrative insider transaction for tax purposes, which is common practice for executives receiving equity compensation. It does not reflect a discretionary sale based on new company performance insights or broader industry trends.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a pre-scheduled, non-discretionary sale for tax purposes, not indicative of a change in management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/31/2023 | Date Rule 10b5-1 instruction letter was adopted. |
| 07/15/2023 | Date after which RSUs vested, triggering the tax withholding obligation. |
| 03/17/2026 | Date of the reported transaction (sale of common stock). |
| 03/19/2026 | Date the Form 4 was signed by the reporting person. |
Keywords
Revolution Medicines, RVMD, Jack Anders, CFO, Insider Trading, Form 4, Stock Sale, Rule 10b5-1, Restricted Stock Units, RSU Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.